Stay updated on PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Sign up to get notified when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.

Latest updates to the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link has been removed, with no other substantive changes to core content.SummaryDifference0.4%
- Check13 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%
- Check20 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of a new drug, zirconium-89-trastuzumab, while previous location details and drug information have been removed.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
Stay in the know with updates to PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.